治疗性疫苗国内外研发现状与发展趋势

121231*2311．3100522．3100523．310052、。。。S188A0517－6611201336－13917－031890Koch1。、72－4。、、、5。。1、、6－7。/、8。、。、、9－11。113－16/1MelacineCorixaGSK/1999ⅢFDAFDA2DCVax-Brain/2007II3OncophageAntigenicsgp96/2008FDAFDAEMEA、“”。4OncoVaxVicalIncorporat-edBCG、/20082011FDA5M-VaxAVAXDNP/2000、/20051999FDA“”6CIMACAXEGFＲ/20087ProvengeDendreon/2010FDA1986－。*。2013-12-0222．115JournalofAnhuiAgri．Sci．2013413613917－1391913939、、、、、、HIV、、3/412。71ProvengeFDAEMA2－4。2．230068%HBV、HIV、1217。120122Ⅱ、Ⅲ1Allovectin-7VicalⅢMHC-IDNA2Belagenpumatucel-LNovaＲxⅢTGF-beta23BLP-25MerckSeronoⅢMuc14BiovaxIDBiovestⅢ5TG4010TransgeneⅢMUC-1-26TroVaxOxfordⅢ5T47LucanixNovaＲxⅢTGF-beta28AGS-004ArgosTherapeuticsHIVⅡＲNA9DermaVirGeneticImmunityHIVⅡDNA10DiamydDiamydmedicalⅠⅢGADⅠ11IC41IntercellⅡ512MVA-BBavarianNordicHIVⅡ413TovaxinOpexaⅡT14GI-5005GlobeImmuneⅡHCVNS3。。、18。。33．1HBV、900019。9300280020。3．1．1。HBsAgHBVFc2007Ⅲ2011E21－22。3．1．2。458819312013DNAPCＲHBVpreS2．SIL-2/IFN-γHBV。Ⅰ23。3．2。Ⅱ24。———APDC。2012SFDAⅢ25。、2011ⅠHIV26。、。1/3。44。。4．1、、“”。。。Ⅲ。。4．227。。。、、。Ⅲ。。M-VaxMelacine28。5FDA44%、AIDS、、、。5、、、、。。。1KIＲKWOODJMBUTTEＲFIELDLHTAＲHINIAAetal．Immunother-apyofCancerin2012J．CACancerJournalforClinicians2012625309－335．2KEIJZEＲCVANDEＲZEEＲVANEDENWetal．Treginducingadju-vantsfortherapeuticvaccinationagainstchronicinflammatorydiseasesJ．FrontImmunol2013204245．3MADANＲASCHWAABTGULLEYJL．Strategiesforoptimizingtheclinicalimpactofimmunotherapeuticagentssuchassipuleucel-Tinpros-tatecancerJ．JNatlComprCancNetw201210121505－1512．4AKBAＲSMAL-MAHTABMUDDINMHetal．HBsAgHBcAgandcombinedHBsAg/HBcAg-basedtherapeuticvaccinesintreatingchronichepatitisBvirusinfectionJ．HepatobiliaryPancreatDisInt2013124363－369．5ＲethinkingtherapeuticcancervaccinesJ．NatＲevDrugDiscov20098685－686．6GONZALEZGCＲOMBETTLAGEA．Chronicvaccinationwithathera-peuticEGF-basedcancervaccineareviewofpatientsreceivinglonglast-ingtreatmentJ．CurrCancerDrugTargets2011111103－110．7SCHLOMJGULLEYJLAＲLENPM．ParadigmshiftsincancervaccinetherapyJ．ExpBiolMedMaywood2008233522－534．139399193141361、∥kg186．72±18．06113．67±17．62∥cm128．70±10．5694．83±2．57∥cm133．00±7．32103．00±2．65∥cm139．89±5．23120．50±4．82∥cm14．01±1．1112．67±1．15∥kg186．72±18．06113．67±17．62∥kg12．03±2．016．57±0．12∥kg12．17±2．166．83±0．81∥kg2．58±0．261．48±0．08∥kg2．86±0．321．52±0．13∥kg0．67±0．460．28±0．09∥kg1．00±0．660．40±0．02∥kg80．30±15．7648．57±7．39∥kg60．12±10．1236．87±4．54∥kg20．18±7．1611．47±1．51∥%43．01±2．8642．47±0．92∥%32．20±3．0232．54±1．26∥%74．86±2．9776．12±2．11∥g/kg0．24±0．120．33±0．10∥g/kg2．79±1．122．06±1．12∥g/kg0．83±0．100．65±0．06∥g/100g11．22±0．829．68±0．171．M．2002．2．J．20095111－112．3．、J．20082637－10．4．M．2002．5．M．2010．6．J．20111013－14．7．J．201029667－68．8．F1J．2005253檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪檪57－58．139198VANDOOＲSLAEＲKＲEIMEＲSLLSTUDENTSOＲYYetal．Serologi-calresponsetoanHPV16E7basedtherapeuticvaccineinwomenwithhigh-gradecervicaldysplasiaJ．GynecolOncol20101162208－212．9PALUCKAKBANCHEＲEAUJ．Dendritic-cell-basedtherapeuticcancervaccinesJ．Immunity201339138－48．10TOPALIANSLWEINEＲGJPAＲDOLLDM．CancerimmunotherapycomesofageJ．ClinOncol201129364828－4836．11ＲOTHSCHILDSZIPPELIUSA．Cancerimmunotherapy-novelperspec-tivesJ．TherUmsch20126910559－563．12KIESSLINGAFUSSELSWEHNEＲＲetal．Advancesinspecificim-munotherapyforprostatecancerJ．EurUrol2008534694－708．13HAMMEＲSTＲOMAECAULEYDHATKINSONBJetal．Cancerim-munotherapysipuleucel-TandbeyondJ．Pharmacotherapy2011318813－828．14SOSMANJASONDAKVK．MelacineanallogeneicmelanomatumorcelllysatevaccineJ．ExpertＲevVaccines200323353－368．15DIPIETＲOATOSTIGFEＲＲUCCIPFetal．OncophagesteptothefutureforvaccinetherapyinmelanomaJ．ExpertOpinBiolTher20088121973－1984．16ＲODＲGUEZPCＲODＲGUEZGGONZLEZGetal．Clinicaldevel-opmentandperspectivesofCIMAvaxEGFCubanvaccinefornon-small-celllungcancertherapyJ．MEDICCＲev201012117－23．17GUOCMANJILIMHSUBJECKJＲetal．Therapeuticcancervac-cinespastpresentandfutureJ．AdvCancerＲes2013119421－475．18WANGSCHENYW．Currentdevelopmentsituationofbiologicalmedi-cineindustrialparksandcountermeasuresinChinaJ．ChinesePharma-ceuticalAffairs201226101048－1051．19LIUSQGAOYQ．TheＲesearchdevelopmentofHBeAg-negativechron-ichepatitisBJ．ChineseHepatology2012176429－432．20FANGXLIANGZL．TheresearchdevelopmentofviralhepatitisvaccineinChinaJ．ChinPharmJ201247181425－1429．21WENYM．TheresearchdevelopmentofTherapeuticvaccinesJ．Chi-neseJournalofMicrobiologyandImmunology1996163155－158．22WENYMHELFQUT．Theresearchdevelopmentoftherapeuticre-combinanthepatitisBvaccineYICJ．EngineeringScience19991138－4257．23CHENGM．DevelopmentandapplicationoftherapeuticHBVDNAvac-cineJ．MedJChinPLA2003288489－492．24WANGYB．PreparationofMouse-anti-humanATPSynthaseF1DomainMonoclonalAntibodyandItsEffectsonProliferationandInvasionofCellsofPrimaryLiverCarcinomaD．ShanghaiTheSecondMilitaryMedicineUniversity2009．25CAOXT．DifferentiationantigenpresentationandfunctionalregulationofdendriticcellsJ．AeadJSecMilMedUni2004253547－549．26CAOZLZHUSL．TheepidemiologyandcurrentresearchofvaccineofHIV/AIDSinChinaJ．ActaAcademiaeMedicinaeCPAF20112010842－844．27GENGYHYANGLBIDZ．TheprogressofLiposomesasimmunologi-caladjuvantsJ．ChinPharmJ2007429649－651．28WUWTWANGYTWUWJ．Thesustainedandrapiddevelopmento